Compare LQDA & BKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LQDA | BKH |
|---|---|---|
| Founded | 2004 | 1941 |
| Country | United States | United States |
| Employees | N/A | 2795 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.4B |
| IPO Year | 2020 | 2001 |
| Metric | LQDA | BKH |
|---|---|---|
| Price | $68.49 | $70.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $41.00 | ★ $77.80 |
| AVG Volume (30 Days) | ★ 963.9K | 765.6K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.78% |
| EPS Growth | ★ 51.81 | 1.79 |
| EPS | 1.26 | ★ 2.23 |
| Revenue | $158,320,000.00 | ★ $2,310,000,000.00 |
| Revenue This Year | $278.87 | $4.98 |
| Revenue Next Year | $57.13 | $3.92 |
| P/E Ratio | $56.31 | ★ $31.36 |
| Revenue Growth | ★ 1031.18 | 8.57 |
| 52 Week Low | $21.35 | $59.33 |
| 52 Week High | $93.61 | $78.69 |
| Indicator | LQDA | BKH |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 44.48 |
| Support Level | $62.86 | $68.06 |
| Resistance Level | $92.35 | $74.96 |
| Average True Range (ATR) | 2.78 | 1.40 |
| MACD | 0.69 | -0.08 |
| Stochastic Oscillator | 66.74 | 26.51 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.